Cargando…

Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer

BACKGROUND: The incidence rate of gastric cancer in western countries has shown a remarkable decline in the recent years while it is still the most common cancer among males in Iran. The proto-oncogene MYC, located at 8q24.1, regulates almost 15% of human genes and is activated in 20% of all tumors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Khaleghian, Malihea, Jahanzad, Issa, Shakoori, Abbas, Emami Razavi, Amirnader, Azimi, Cyrus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863201/ https://www.ncbi.nlm.nih.gov/pubmed/27175302 http://dx.doi.org/10.5812/ircmj.21221

Ejemplares similares

Study of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods
por: Khaleghian, Malihea, et al.
Publicado: (2015)

A retrospective chromosome studies among Iranian infertile women: Report of 21 years
por: Azimi, Cyrus, et al.
Publicado: (2013)

Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.
por: Masramon, L., et al.
Publicado: (1998)

Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
por: Mirzania, Mehrzad, et al.
Publicado: (2017)

Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Yang, Jinlin, et al.
Publicado: (2014)

A retrospective institutional study of histopathologic pattern of Oral Squamous Cell Carcinoma (OSCC) in Tehran, Iran during 2006-2015
por: Ghafari, Ramin, et al.
Publicado: (2019)

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification
por: Lin, Xiaoyi, et al.
Publicado: (2022)

Association between the Expression Levels of MicroRNA-101, -103, and -29a with Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients
por: Tutunchi, Sara, et al.
Publicado: (2022)

Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines
Publicado: (1987)

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity
por: Razavi, Amirnader Emami, et al.
Publicado: (2012)

Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study
por: Kamranzadeh, Hosein, et al.
Publicado: (2019)

MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma
por: Qin, Jing, et al.
Publicado: (2021)

Association between c-Myc Expression with Clinicopathological Features in T And NK Cell Lymphomas
por: Hasenan, Nasrun, et al.
Publicado: (2021)

Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: AXL, GAS6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer
por: HASSANI, Elham, et al.
Publicado: (2019)

HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression
por: Mirmohseni Namini, Nazanin, et al.
Publicado: (2021)

The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Min, Zhao, et al.
Publicado: (2021)

Dissecting transcriptional amplification by MYC
por: Nie, Zuqin, et al.
Publicado: (2020)

Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis
por: Scorilas, A, et al.
Publicado: (1999)

MYC amplification in leukemia detected by cytogenetics
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2021)

The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People
por: Shahsavari, Gholamreza, et al.
Publicado: (2019)

Primary Non-Hodgkin Lymphoma of the Stomach: Clinicopathological Characteristics and Prognostic Factors in Iranian Patients
por: Hosseini, Sare, et al.
Publicado: (2014)

Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach
por: Lin, Jian-Xian, et al.
Publicado: (2021)

hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer
por: Elkak, AE, et al.
Publicado: (2005)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Registered report: Transcriptional amplification in tumor cells with elevated c-Myc
por: Blum, David, et al.
Publicado: (2015)

Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
por: Lewis, L Michelle, et al.
Publicado: (2018)

The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer
por: Pan, Weiyu, et al.
Publicado: (2020)

Evaluation of squamous cell carcinoma antigen 1 expression in oral squamous cell carcinoma (tumor cells and peritumoral T-lymphocytes) and verrucous carcinoma and comparison with normal oral mucosa
por: Derakhshan, Samira, et al.
Publicado: (2021)

Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor “CFIm25”
por: Tamaddon, Mona, et al.
Publicado: (2020)

Amplification of Both c‐myc and c‐raf‐1 Oncogenes in a Human Osteosarcoma
por: Ikeda, Shogo, et al.
Publicado: (1989)

Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
por: Seo, A N, et al.
Publicado: (2014)

Plasmablastic Lymphoma of the Stomach With C-MYC Rearrangement in an Immunocompetent Young Adult: A Case Report
por: Huang, Xin, et al.
Publicado: (2015)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Detection of MYC gene amplification in malignant lymphomas.
por: Park, C. K., et al.
Publicado: (1998)

MYC amplifications are common events in childhood osteosarcoma
por: De Noon, Solange, et al.
Publicado: (2021)

Overexpression and Amplification of the c‐myc Gene in Mouse Tumors Induced by Chemicals and Radiations
por: Niwa, Ohtsura, et al.
Publicado: (1989)

MYC Deregulation in Gastric Cancer and Its Clinicopathological Implications
por: de Souza, Carolina Rosal Teixeira, et al.
Publicado: (2013)

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer
por: Baek, Sun Kyung, et al.
Publicado: (2011)

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

Clinicopathological Characteristics of PIK3CA Mutation and Amplification in Korean Patients with Breast Cancers
por: Lee, Moo-Hyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9f2ohmj5hmgj235p41j66h5hg4